Migraine and Stroke: Data Are Accumulating
By Matthew E. Fink, MD
Professor and Chairman, Department of Neurology, Weill Cornell Medical College; Neurologist-in-Chief, New York Presbyterian Hospital
Dr. Fink reports he is a retained consultant for Procter & Gamble and Pfizer.
SOURCE: Androulakis XM, et al. Ischemic stroke subtypes and migraine with aura in the ARIC study. Neurology 2016;87:2527-2532.
The Atherosclerosis Risk in Communities study (ARIC) is a prospective, longitudinal, community-based cohort study that started in 1993, and followed all vascular events, including stroke, for the subsequent 20 years. At time of enrollment, patients had to be in the age group of 45-64 years, and the mean age of the patients was 59 years at the third clinical visit of follow-up. All strokes are classified as either cardioembolic, lacunar, or thrombotic. Of 12,758 participants, there were 1,622 migraineurs. When compared to non-headache patients, there was a significant association between those patients who had migraine with visual aura and ischemic stroke, with a hazard ratio (HR) = 1.7 (95% confidence interval [CI], 1.2-2.6; P = 0.008). Migraine without visual aura was not significantly associated with ischemic stroke compared to non-headache participants. Among the three stroke types categorized in this study, migraine with visual aura was significantly associated only with cardioembolic stroke (HR, 3.7; 95% CI, 1.6-8.7; P = 0.003). The relationship between migraine and stroke is controversial, and findings vary across different population studies. This study shows a strong association between cardioembolic ischemic stroke and migraine with visual aura, but it does not explain the pathophysiology and mechanism for this association. The authors proposed that migraine may predispose to atrial fibrillation, but this is a purely speculative mechanism.
The relationship between migraine and stroke is controversial, and findings vary across different population studies.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.